© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Formulary
Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations
June 30, 2020
FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.
5 Developments Changing the CAR-T Landscape
June 28, 2020
An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.
Out-of-Pocket Costs for Diabetes Medicine Eliminated
January 31, 2020
New plan from CVS Caremark eliminates member cost as a barrier to medications without raising costs for benefits, premiums or deductibles.
Top Issues Facing Pharma in 2020
January 11, 2020
Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.
Will Outcomes-Based Payments Hit COPD Drugs?
November 29, 2018
In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?
Will Drug Price Hikes Impact Drug Spending?
November 28, 2018
Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causes
November 07, 2017
Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.